EBD Group is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

2019 Public Presentation Information

Fee structure
  • Presentation fee per company:  $3,950
  • Registration fee per presenter: $1,995          
  • Total fee: $5,945
    • (Presentation fee + One registration for presenter)

Click here for information on cancellation policy, payments, and sending a replacement.

Who should present?

Biotech Showcase offers mid-, small- and micro-cap publicly traded life science companies an opportunity to present, build their profile, conduct one-to-one meetings and network with investors and potential strategics. Building a profile and becoming "known" is a critical part of raising money.

Biotech Showcase features companies in the following broad groups:

Categories:
- Small and large molecule R&D therapeutic companies
- Platform companies
- Tool companies
- Delivery companies
- Molecular diagnostic and personalized medicine companies
- Research focused service providers

MARKETING AND PROMOTIONAL SUPPORT FOR PRESENTING COMPANIES:

Presentation Slots:
  • 30-minute company presentation slot with PowerPoint slides (includes two-minute introduction and transition time, actual presentation 28 minutes)
  • Breakout Rooms will be located in the presenting company area for quick access directly after presentations.
  • Companies will be grouped by broad categories in order to make it easier for investors to locate them.
Marketing:

We continue to enhance marketing efforts for presenting companies. These activities include:

  • Posting company name, date and time of presentation on the Bloomberg calendar which is distributed on all Bloomberg terminals.
  • Two unique Twitter posts per company, indicating selection to present and presentation date and time.
  • Promotional emails and posts on all media channels leading up to the conference.
  • Grouping companies in broad therapeutic areas to make it easier for investors to find them.
  • Distribution of presenting company list to pharma and investors to support organizing meetings.
Onsite Interviews:

(please note, companies are selected for onsite interviews by the press, and we cannot guarantee that your company will be interviewed):

  • Limited to 100 selected companies.
  • A 7-8 minute video will be posted shortly after the conclusion of the interview to investor channels and will be made available to the company.
  • A journalist will write a brief story to accompany the interview and this will be distributed through major financial channels.
Media:
  • Press Room: In 2019, the press room will accommodate the growing number of onsite journalists. In 2018, 70 journalists were onsite, and we expect this number to grow.
  • Embargoed News: Companies with important announcements are encouraged to embargo their news and release it at the event. Our team will provide the press with a list of companies announcing news.
  • Press Releases: Press releases provided by presenting companies will be distributed to our network of investors, pharma and biotech execs via our social media channels.
  • Press Release Templates: A press release template to announce that the company has been selected to present and another press release template to announce the date/time of the presentation will be provided to presenters.